Total Payments
$1,237
2024 Payments
$105.89
Companies
22
Transactions
82
Medicare Patients
950
Medicare Billing
$54,955
Payment Breakdown by Category
Food & Beverage$1,169 (94.5%)
Education$68.17 (5.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,169 | 76 | 94.5% |
| Education | $68.17 | 6 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $154.20 | 11 | $0 (2019) |
| Novo Nordisk Inc | $127.96 | 10 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $116.70 | 10 | $0 (2017) |
| Amgen Inc. | $115.54 | 8 | $0 (2019) |
| Sensible Medical Innovations Inc | $105.89 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $97.78 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $82.32 | 6 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $73.89 | 6 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $46.21 | 2 | $0 (2021) |
| Shire North American Group Inc | $36.10 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.89 | 1 | Sensible Medical Innovations Inc ($105.89) |
| 2021 | $23.58 | 1 | E.R. Squibb & Sons, L.L.C. ($23.58) |
| 2020 | $22.63 | 1 | E.R. Squibb & Sons, L.L.C. ($22.63) |
| 2019 | $201.07 | 14 | Amgen Inc. ($46.77) |
| 2018 | $342.47 | 24 | Lilly USA, LLC ($71.92) |
| 2017 | $541.03 | 41 | Sunovion Pharmaceuticals Inc. ($116.70) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2024 | Sensible Medical Innovations Inc | ReDS system (Device) | Food and Beverage | Cash or cash equivalent | $105.89 | General |
| Category: ReDS system | ||||||
| 01/27/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $23.58 | General |
| Category: Cardiovascular | ||||||
| 09/16/2020 | E.R. Squibb & Sons, L.L.C. | ABILIFY (Drug) | Education | Cash or cash equivalent | $22.63 | General |
| Category: Neuroscience | ||||||
| 06/13/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 06/10/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Respiratory | ||||||
| 05/30/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/23/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/11/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Diabetes | ||||||
| 03/26/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Neuroscience | ||||||
| 02/14/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Bone Health | ||||||
| 01/31/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/29/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2019 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: UROLOGY | ||||||
| 01/11/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Neuroscience | ||||||
| 12/18/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Endocrinology | ||||||
| 11/27/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Neuroscience | ||||||
| 11/15/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: DIABETES | ||||||
| 11/08/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 11/06/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, COLOGUARD | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/25/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Neuroscience | ||||||
| 10/04/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 10/02/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 154 | 196 | $28,040 | $9,582 |
| 2022 | 9 | 259 | 327 | $41,808 | $14,178 |
| 2021 | 8 | 277 | 370 | $42,431 | $14,252 |
| 2020 | 8 | 260 | 462 | $48,364 | $16,943 |
Total Patients
950
Total Services
1,355
Medicare Billing
$54,955
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 42 | $11,340 | $3,905 | 34.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 58 | $8,120 | $3,287 | 40.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 30 | 33 | $5,280 | $1,977 | 37.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 23 | $1,380 | $218.96 | 15.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 37 | 40 | $1,920 | $193.44 | 10.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 97 | $13,580 | $5,171 | 38.1% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 29 | 30 | $7,050 | $2,716 | 38.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $7,290 | $2,552 | 35.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 21 | $3,360 | $1,131 | 33.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 16 | 34 | $2,584 | $872.53 | 33.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 14 | 14 | $2,100 | $699.81 | 33.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 12 | 12 | $1,092 | $441.95 | 40.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 61 | 64 | $3,072 | $325.55 | 10.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 26 | 28 | $1,680 | $268.06 | 16.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 81 | $11,340 | $4,359 | 38.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 28 | $7,560 | $2,629 | 34.8% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 23 | 26 | $6,110 | $2,404 | 39.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 29 | 79 | $6,004 | $2,163 | 36.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 25 | 26 | $4,160 | $1,383 | 33.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 15 | 15 | $1,365 | $564.20 | 41.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 81 | 84 | $4,032 | $448.88 | 11.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 27 | 31 | $1,860 | $301.01 | 16.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 42 | 86 | $12,040 | $4,638 | 38.5% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 38 | 134 | $10,184 | $3,796 | 37.3% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 26 | 26 | $6,110 | $2,716 | 44.5% |
About Dr. Gregory Heumann, MD
Dr. Gregory Heumann, MD is a Internal Medicine healthcare provider based in North Vernon, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346213790.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Heumann, MD has received a total of $1,237 in payments from pharmaceutical and medical device companies, with $105.89 received in 2024. These payments were reported across 82 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,169).
As a Medicare-enrolled provider, Heumann has provided services to 950 Medicare beneficiaries, totaling 1,355 services with total Medicare billing of $54,955. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location North Vernon, IN
- Active Since 02/08/2006
- Last Updated 06/29/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346213790
Products in Payments
- TRULICITY (Drug) $142.30
- Victoza (Drug) $127.96
- LATUDA (Drug) $108.63
- ReDS system (Device) $105.89
- Myrbetriq (Drug) $76.29
- Aimovig (Biological) $60.82
- Prolia (Biological) $54.72
- ENTRESTO (Drug) $53.01
- XARELTO (Drug) $52.65
- VYVANSE (Drug) $36.10
- RELISTOR ORAL (Drug) $35.61
- AIMOVIG (Biological) $29.31
- Vascepa (Drug) $27.03
- TROKENDI XR (Drug) $23.65
- ELIQUIS (Drug) $23.58
- SOLIQUA (Drug) $22.72
- ABILIFY (Drug) $22.63
- VESICARE (Drug) $21.49
- INVOKANA (Drug) $21.24
- VRAYLAR (Drug) $17.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Vernon
Adnan Khan, M.d, M.D
Internal Medicine — Payments: $1,824
Internal Medicine $1,824
Dr. Scott Robinson, M.d, M.D
Internal Medicine — Payments: $107.06
Internal Medicine $107.06
Judith Koehler, Md, MD
Internal Medicine
Internal Medicine
Dr. Sweet Allen, M.d, M.D
Internal Medicine
Internal Medicine
Dr. Zachary Tucker, M.d, M.D
Internal Medicine
Internal Medicine